PTGS2 and cancer: The upregulation of COX-2 leads to increased prostaglandin synthesis, which in turn promotes cancer cell proliferation, increases inflammatory response, and stimulates angiogenesis within the tumor microenvironment, thereby potentially promoting cancer progression (Zhou et al., 2022; Xia et al., 2018).